Showing 1 - 20 results of 83 for search '"Безопасность и риск фармакотерапии"', query time: 0.05s Refine Results
  1. 1
    Drug Safety Monitoring Information

    Drug Safety Monitoring Information by E. V. Shubnikova, E. O. Zhuravleva, N. Yu. Velts, P. M. Giulakhmedova, A. A. Druzhinina

    Published 2021-07-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Comparative Preclinical Evaluation of the Safety, Antifungal Activity, and Pharmacokinetics of Sertaconazole Products for External Use

    Comparative Preclinical Evaluation of the Safety, Antifungal Activity, and Pharmacokinetics of Sertaconazole Products for External Use by V. M. Kosman, M. V. Karlina, V. A. Vavilova, K. E. Borovkova, K. L. Kryshen, N. V. Marchenko, S. A. Kopatko, I. V. Sychkova, D. R. Kargopoltseva, M. N. Makarova, V. G. Makarov

    Published 2024-04-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Safety of COVID-19 vaccines

    Safety of COVID-19 vaccines by B. K. Romanov

    Published 2022-12-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Antibiotics for the treatment of COVID‐19

    Antibiotics for the treatment of COVID‐19 by article Editorial

    Published 2022-07-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Erratum: Velts N.Yu. et al. Submission of Documents on the Pharmacovigilance System as Part of the Registration Dossier within the Framework of the EAEU Procedures: Analysis of Requirements and Typical Errors

    Erratum: Velts N.Yu. et al. Submission of Documents on the Pharmacovigilance System as Part of the Registration Dossier within the Framework of the EAEU Procedures: Analysis of Req... by Article Editorial

    Published 2024-12-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Local Administration of pCMV-VEGF165 Plasmid Encoding VEGF Stimulates Tissue Regeneration after Cold Injury in Rats

    Local Administration of pCMV-VEGF165 Plasmid Encoding VEGF Stimulates Tissue Regeneration after Cold Injury in Rats by O. V. Shcheblykina, D. A. Kostina, V. V. Arkhipov, E. A. Patrakhanov, A. A. Dolzhikov, V. V. Gureev, N. I. Zhernakova, O. A. Osipova, M. V. Pokrovskii

    Published 2025-06-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Analysis of Pharmacokinetic Parameters of Acetylsalicylic Acid for Prediction of Potential Nephrotoxic Effects

    Analysis of Pharmacokinetic Parameters of Acetylsalicylic Acid for Prediction of Potential Nephrotoxic Effects by L. M. Krasnykh, O. A. Goroshko, G. F. Vasilenko, G. I. Gorodetskaya, V. V. Smirnov, T. A. Rodina

    Published 2021-12-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Opportunities and Prospects for Preclinical Drug Safety Assessment Using Alternative Methods: Experience from the Toxicology in the 21st Century (Tox21) Programme in the USA

    Opportunities and Prospects for Preclinical Drug Safety Assessment Using Alternative Methods: Experience from the Toxicology in the 21st Century (Tox21) Programme in the USA by V. N. Perfilova

    Published 2024-04-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Editorial

    Editorial by B. K. Romanov, A. E. Krasheninnikov

    Published 2018-02-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Drug-Induced Heart Failure (Part 2: Mechanisms of Development, Clinical Signs, Differential Diagnosis, Risk Factors, Treatment and Prevention)

    Drug-Induced Heart Failure (Part 2: Mechanisms of Development, Clinical Signs, Differential Diagnosis, Risk Factors, Treatment and Prevention) by O. D. Ostroumova, I. V. Goloborodova

    Published 2020-06-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Risk Management in Preclinical Trials as Part of an Overall Integrated Quality Management System

    Risk Management in Preclinical Trials as Part of an Overall Integrated Quality Management System by M. A. Zaytseva, M. B. Ivanov, A. B. Verveda, L. V. Lyanginen

    Published 2020-03-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Changes in Post-COVID Syndrome Manifestations and Bulbar Conjunctival Angioscopy Results in a Patient Undergoing Treatment after Mild COVID-19

    Changes in Post-COVID Syndrome Manifestations and Bulbar Conjunctival Angioscopy Results in a Patient Undergoing Treatment after Mild COVID-19 by V. V. Arkhipov, T. S. Kheilo, E. G. Gladysheva, Yu. A. Danilogorskaya, M. R. Dzhavatkhanova, S. V. Snytko, I. V. Samorukova, M. V. Zhuravleva

    Published 2022-04-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Good Pharmacovigilance Practice in the United States and the European Union

    Good Pharmacovigilance Practice in the United States and the European Union by V. A. Merkulov, N. D. Bunyatyan, A. P. Pereverzev

    Published 2022-06-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    «Propofol infusion syndrome» - case in a child of 10 years

    «Propofol infusion syndrome» - case in a child of 10 years by S. S. Postnikov, M. N. Kostyleva, G. P. Bryusov

    Published 2018-02-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Role of Pharmacogenetic Testing in the Risk and Safety Assessment of Valproates: The Ethnic Aspect (Review)

    Role of Pharmacogenetic Testing in the Risk and Safety Assessment of Valproates: The Ethnic Aspect (Review) by N. A. Shnayder, V. V. Grechkina, V. V. Arkhipov, R. F. Nasyrova

    Published 2024-07-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    A REVIEW OF CASES OF DEVELOPMENT OF ACUTE HEPATIC INSUFFICIENCY DUE TO THE INTAKE OF BIOLOGICALLY ACTIVE ADDITIVES

    A REVIEW OF CASES OF DEVELOPMENT OF ACUTE HEPATIC INSUFFICIENCY DUE TO THE INTAKE OF BIOLOGICALLY ACTIVE ADDITIVES by M. L. Maksimov, S. A. Simakova

    Published 2018-06-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    Toxicity Associated with Immune Checkpoint Inhibitors: Analysis of Immune-Related Adverse Events with a Pembrolizumab Biosimilar (Pembroria)

    Toxicity Associated with Immune Checkpoint Inhibitors: Analysis of Immune-Related Adverse Events with a Pembrolizumab Biosimilar (Pembroria) by M. Yu. Fedyanin, A. V. Snegovoy, V. V. Breder, Yu. N. Linkova, A. V. Zinkina-Orikhan, S. B. Setkina, S. N. Fogt, V. S. Chistiakov, N. A. Kravtsova

    Published 2023-06-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    RETROSPECTIVE ANALYSIS OF REPORTED CASE OF ADVERSE DRUG REACTION - NEUROLEPTIC MALIGNANT SYNDROME ON THE USE OF HALOPERIDOL

    RETROSPECTIVE ANALYSIS OF REPORTED CASE OF ADVERSE DRUG REACTION - NEUROLEPTIC MALIGNANT SYNDROME ON THE USE OF HALOPERIDOL by V. V. Arkhipov, N. G. Berdnikova, M. V. Zhuravleva, V. G. Kukes

    Published 2018-02-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  19. 19
    Modern methods of identification of adverse events associated with medication errors

    Modern methods of identification of adverse events associated with medication errors by A. P. Pereverzev, S. K. Zyryanov, Y. Sh. Guschina

    Published 2018-02-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:
  20. 20
    Signal Management: Updated Requirements of the EAEU Good Pharmacovigilance Practice

    Signal Management: Updated Requirements of the EAEU Good Pharmacovigilance Practice by A. V. Matveev, A. E. Krasheninnikov, A. Yu. Zelinskaya

    Published 2023-03-01
    “…Безопасность и риск фармакотерапии…”
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: